LifeMD, Inc. (LFMD) Misses Q2 EPS by 6c

LifeMD, Inc. (NASDAQ: LFMD) reported Q2 EPS of ($0.16), $0.06 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $49.15 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
• JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight